Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Abstract Full Text Services Email this article Alert me to new content in the JEM Citing Articles Citing Articles via CrossRef

Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20070863
Albu et al.

• Figure S1 Selective removal of BCL11B starting with DP thymocytes.

• Figure S2 BCL11B^F/FCD4cre/ OT2 and BCL11B^F/FCD4cre/HYTCR mice present enlarged spleens and mesenteric lymph nodes.

• Figure S3 IP3R expression is not affected in BCL11B-deficient DP thymocytes.

• Figure S4 BCL11B-overexpressing cells are more resistant to dexamethasone-induced cell death.

• Figure S5 Provision of BCL2 does not restore positive selection of BCL11B^F/F CD4cre DP thymocytes and CD4 and CD8 SP thymocyte populations.

• Table S1 Splenic cellularity of BCL11B^F/FCD4Cre/TCRα^-/-mice

• Table S2 Absolute numbers of thymocytes in mice reconstituted with bone marrow from TCR OT2 transgenics

• Supplemental text (PDF)

This Article Abstract Full Text Services Email this article Alert me to new content in the JEM Citing Articles Citing Articles via CrossRef